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Interleukin-1 (IL-1) may have a significant pro-inflamma-
tory effect in the skin; an imbalance in its production has been 
linked to cutaneous disease processes. IL-l receptor antago-
nist (IL-1ra) is a recently described competitive inhibitor of 
IL-la and IL-1/3 that binds to human types I and II IL-1 
receptors without apparent cell activation. Human keratino-
cytes synthesize IL-lra, IL-1a, and IL-1/3 but fail to secrete 
these cytokines. This study investigated IL-1ra and IL-1a 
accumulation by cultured keratinocytes stimulated by tumor 
necrosis factor-a (TNF-a), IL-3, IL-4, IL-6, IL-10, inter-
feron-y, granulocyte-macrophage colony-stimulating factor, 
granulocyte colony-stimulating factor, and macrophage col-
ony-stimulating factor and by various extracellular matrix 
proteins, conditions that these cells may encounter in normal 
or inflamed skin in vivo. IL-1ra and IL-1a proteins were 
measured by specific enzyme-linked immunosorbent assay in 
keratinocyte supernatants and lysates. Only TNF-a induced 
IL-1 ra and IL-la production. TNF-a added to culture in 
amounts of10 ng/ml or higher, induced a twofold increase in 
intracellular levels of both IL-ra and IL-la without secretion 
at 48 h. The IL-1ra concentration in keratinocyte lysates in-
T he interleukin-l (IL-l) family ofcytokines consists of three homologous molecules: two agonists (IL-la and IL-IP) and the IL-l receptor antagonist (IL-l ra) [1]. IL-la and IL-1P each bind to both types I and II IL-l receptors and induce similar biologic responses 
in target cells. The primary agonist that keratinocytes produce is 
IL-la, which remains intracellular in the biologically active pre-
cursor form [2] . Although keratinocytes also produce the IL-lp 
precursor, it is not biologically active, and keratinocytes lack the 
IL-IP converting enzyme [3] . Keratinocytes also produce a struc-
tural variant of the originally described monocyte IL-l ra that lacks a 
signal peptide and also remains intracellular [4-7]. IL-lra binds to 
both types of human IL-l receptors and is a competitive inhibitor of 
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creased from 9.6 to 17 .6ng/ml after TNF-a stimulation, and 
the IL-la concentration increased from 1.0 to 3.3 ng/ml. 
Keratinocytes also exhibited comparable increases in IL-1a 
and IL-1ra mRNA levels after 12 h in culture with TNF-a, 
as determined by il1 vitro hybridization to specific eDNA 
probes. The IL-la and IL-lra response to TNF-a stimula-
tion showed a varied pattern among different keratinocyte 
strains over 72 h of culture on plain plastic. In contrast, ex-
tracellular matrix proteins (laminin, fibronectin, collagen I 
and IV, and vitronectin) did not stimulate keratinocyte accu-
mulation of IL-la or IL-lra proteins after 72 h in culture. 
When TNF-a was added to cells cultured on these matrices, 
no change in IL-1a or IL-1 ra production was observed above 
that which could be attributed to TNF-a alone. In conclu-
sion, TNF-a, but not the extracellular matrix proteins tested, 
stimulated production of intracellular IL-1a and IL-1ra by 
keratinocytes. The ratio of IL-lra to IL-1a after TNF-a 
stimulation of keratinocytes may influence the inflammatory 
profile in the epidermis. ] Itwest Dermatol 101 :79 - 85, 
1993 
both IL-la and IL-IP [8,9] . The degree of differentiation of kerati-
nocytes has been shown to modulate levels of keratinocyte IL-lra 
production [6]. 
The immunologic environment of the skin comprises complex 
interactions of various cytokines. This study examined whether 
epidermal cytokines and matrix proteins, two key elements of the 
epidermal environment, might influence IL-la and IL-lra produc-
tion by cultured keratinocytes. Cytokines that keratinocytes are 
known to produce or respond to were studied for their potential 
effects on IL-la and IL-lra production by keratinocytes. Among 
those cytokines examined were IL-3, IL-4, IL-6 , IL-l0, tumor ne-
crosis factor-a (TNF-a) , interferon-y, granulocyte-macrophage col-
ony-stimulating factor, granulocyte colony-stimulating factor, and 
macrophage colony-stimulating factor. 
Extracellular matrix proteins (ECMP) may also influence the bio-
logic functions of keratinocytes. Monocytes grown on collagen 
types I, II, III, and IX produce enhanced levels of IL-l [10] . In 
addition, tissue culture plates coated with anti-CD44, anti-CD45, 
or anti-lymphocyte function-associated-3 antibodies stimulate IL-1 
production by adherent monocytes [11,12]. The effects of ECMP 
on IL-lra and IL-la production by keratinocytes have not previ-
ously been examined. 
The results of our studies indicate that of all the cytokines exam-
ined, only TNF-a induced IL-la and IL-l ra production by kerati-
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Figure 1. Accumulation oflL-lra and IL-Ia by keratinocytes after 48 h of 
stimula tion by various cyrokines. Cytokine-stimulated cultures were all 
from the same keratinocyte strain grown in parallel. Data represent triplicate 
cultures with triplicate samples taken from each culture. IL-la and IL-lra 
values were determined on the same samples from each culture. Cytokines 
were added to cultures 24 h after plating, and supernatants and lysates were 
harvested 48 h later. Parallel control cultures were carried out in the absence 
of cytokines. The data are expressed as total lL-l ra or IL-lex levels (superna-
tants plus lysates) in nanograms per milliliter (mean ± SO; 11 = 9) versus 
cytokine. TO indicates the amounts of IL-1 ra and IL-1a present at the 
beginning of the 48-h culture period. C48 h indicates the proteins present in 
control wells at the end of the 48-h culture. The cytokines were used at the 
following concentrations: IL-3, 100 vlml; IL-4, 100 U/ml; IL-6, 100 
v/ml; IL- lO, 100 U/ml; TNF-a 10 ng/ml; interferon-y (IFN), 50 vlml; 
granulocyte-macrophage colony-stimulating factor (GM-CSF), 100 U Iml; 
granulocyte colony-stimulating factor (G-CSF), 100 vlml; and macro-
phage colony-stimulating factor (M-CSF), 100 vlml. 
nocytes. In addi tion, culture on ECMP failed to stimulate accumu-
lation of IL-la .and IL-l ra in keratinocytes. 
MATERIALS AND METHODS 
Cell CultUJ:e, Medium, and Reagents Neonatal foreskin kera-
tinocytes were grown in keratinocyte serum-free medium (Gibco, 
Grand Island, NY) with 50 flg/ml bovine pituitary extract (Gibco), 
5 ng/mJ recombinant epidermal growth factor (Gibco), and 4 flg/ 
ml gentamicin (Sigma Chemical Co., St. Louis, MO). The method 
of keratinocyte harvest and culture is described in detail elsewhere 
[13,14]. The keratinocytes are referred to as strains, representing 
pooled cells from one or two donors at the second or third passage. 
All keratinocyte cultures were fed twice weekly and incubated at 
35°C and 5% CO2 in a humidified environment with an antibiotic 
and anti-yeast compound (Roccal II, National Laboratories, Mont-
vale, NJ). Keratinocytes were plated on six-well cluster plates (9.6 
cm2/well) (Falcon, Lincoln Park, NJ) at 3.3 X 105 cells/well for 
the cytokine experiments. After 24 h of culture, the supernatants 
and any non-adherent cells were removed, and fresh keratinocyte 
serum-free medium was added at 2 ml/welL The following cyto-
kines then were added to the cells: lL-3 (Genetics Institute, Boston, 
MA) at 100 U/ml (lOU/2-5 ng); IL-4 (DNAX , Palo Alto, CA) at 
100 U/ml (10 U/ng); IL-6 (Amgen, Thousand Oaks, CA) at 100 
U/ml (100 U/ng); IL-lO (DNAX) at 100 V/ml; interferon-y 
(Genzyme, Boston, MA) at 500 V /ml (25 U /ng); granulocyte-ma-
crophage co lony-stimulating factor (Genetics Institute) at 100 V / 
ml (17 U /ng); granulocyte colony-stimulating factor (Amgen) at 
100 V/ml (100 V/ng); and macrophage colony-stimulating factor 
(Cetus, Branchburg, NJ) at 100 Vim!. Recombinant human TNF-
a (Genzyme) was added to the fresh culture medium to equal final 
concentrations of 10,30, or 100 ng/ml (20 U /ng). After addition of 
the cytokines, the cells were cultured for an additional 12, 24, 48, or 
72 h. Three wells with a cytokine and three control wells without a 
cytokine were harvested at each time point. 
For the ECMP experiments, either one or ten times the recom-
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Figure 2. Response of a keratinocyte strain in which TNF-ll' was added in 
concentrations of 10, 30, or 100 ng/ml 48 h prior to the cell harvest. Th~ 
data are expressed as IL-lra or IL-la concentrations ill cell lysates versus 
concentration of TNF-a added. COlt / lillIS, mean ± SO from nine samples 
(three replicates each for three separate wells). At every TNF-a concentra-
tion examined, the production of lL-l ra and IL-ill' by the stimulated cells 
exceeded the production ofIL-lra and I L-la by the respective control cells 
(p < 0.001). 
mended concentration of each matrix protein was used to coat wells 
according to the manufacturers' directions. The ECMP exaIllined 
were Jaminin, fibronectin, collagen IV, vitronectin (all Sigma), and 
collagen I (Collagen Corp., Palo Alto, CA). Laminin was used at 1 
and lOllg/cm2, fibronectin at 5 and 50 flg/cm2, and collagen 1 at 10 
and 100 flg/ cm2. Second- or third-passage keratinocytes were 
plated on ECMP-coated plates (Falcon) at 4 X 105 cells/well on 
six-wel l cluster plates (35-mm wells) or 1 X 105 cells/well on 24-
well cluster plates (15-mm wells). All cultures then were incubated 
in a humidified environment with Roccal II at 37"C and 5% CO2, 
After 24 h, the medium and any non-adherent cells were removed, 
and fresh medium was added at 2 ml/35-mm well orO.5 mlj15-IllIll 
wel l. The cells were cultured for an additional 12, 24, 48, or 72 h. 
At each time point, three wells containing keratinocytes cultured on 
each ECMP and three control wells without ECMP were harvested. 
Cell Lysis Supernatants were harvested, and non-adherent cells 
were removed by centrifugation at 450 X g for 5 min. An equiva-
lent amount of fresh medium was added to the adherent cells, and 
these were lysed by freeze/thaw three times. Lysates were centri-
fuged at maximum speed in an Eppendorf microcentrifuge for 
15 min to remove cellular debris. Supernatants and lysates were 
stored at -70°C until assayed. 
IL-la Enzyme-Linked Immunosorbent Assay The tech-
nique in our laboratory for a sandwich enzyme-linked immUllosor-
bent assay (ELISA) is described in detail elsewhere [is}. The 
primary antibody, a monoclonal anti - IL-l 0' (Upjohn Co., Kalama-
zoo, MI), was diluted in 0.015 M NaHCOJ buffer (pH 9.6) and was 
used at 400 ng/well of a 96-well ELISA plate (Costar, Van Nuys, 
CA). Non-specific binding sites were blocked with bovine serum 
albumin (Sigma) 5 mg/ml in phosphate-buffered saline. The sec-
ondary antibody was the biotinylated immunoglobulin G fraction 
of a rabbit polyclonal antiserum to IL-la used at a 1/200 dilution in 
1 mg/ml bovine serum albumin/phosphate-buffered saline. The 
standard curve utilized human recombinant IL-la (Hoffman-LaR-
oche, Nutley, N]) in the range 2 ng/ml to 31 pg/ml by serial 
twofold dilutions. Three replicates were analyzed for each test and 
control well; and 50 III of undiluted supernatant or of lysate diluted 
1 : 4 with medium was added to each ELISA well. Streptavidin-per-
oxidase at a 1: 20,000 dilution in phosphate-buffered saline} 
Tweell-20 (Sigma) was allowed to bind to the biotinylated second-
ary antibodies. The enzyme substrate was a solution of 1 mg/ml 
2,2' -azino-bis (3-ethylbellzthiazoline-6-sulfonic acid) (Sigma) and 
0.005% hydrogen peroxide (Sigma) in Mcllvain's buffer (pH 4.6). 
The colorimetric reaction was measured as the ratio of optical den-
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Figure 3. Production of IL-lra by four keratinocytc strains over 72 h. TNF-a 10 ng/ml was added to the cultures 24 h after plating, and supernatants and 
lysates were harvested at 0 time and 12,24,48, and 72 h of culture . Parallel control cultures were carried out in the absence ofTNF-a. The data are expressed as 
tota l IL-1ra produced (supernatants and lysates) in nanograms per milliliter versus time of culture in hours. IL-la and IL-1ra were measured in the same 
samples from cultures harvested at different times. 
sity at wavelengths 405 nm/490 nm. The IL-IO' ELISA was sensi-
tive to 62.5 pg/ml. 
IL-lra ELISA This ELISA is described in detail elsewhere [15). 
The primary antibody used was affinity-purified polyclonal rabbit 
antibodies to recombinant IL-lra at 200 ng/well. The secondary 
antibody was the immunoglobulin G fraction of the rabbit anti-
serum obtained by protein A-affinity chromatography (Pharmacia 
LKB Biotechnology, Piscataway, NJ) and biotinylated utilizing a 
modification of a technique described by Guesdon et al [16). The 
biotinylated secondary antibody was used at a 1 : 20 dilution in 1 
mg/ml bovine serum albuITlin in phosphate-buffered saline/ 
Tween-20. The standard curve utilized recombinant human IL-1 ra 
(Synergen, Boulder, CO) in the range 4 ng/ml to 63 pg/mJ by serial 
twofold dilutions. Again, three replicates were analyzed for each 
test or control well by adding 50 ,ul of undiluted supernatant or of a 
lysate diluted 1 : 6 in medium to each well of an ELISA plate. The 
colorimetric reaction was the same as for the IL-IO' ELISA. The 
IL-lra ELISA was sensitive to 125 pg/ml. 
Slot-Blot Analysis ofIL-10' and IL-lra mRNA Total cellular 
RNA was extracted from cells with guanidine isothiocyanate [17) 
followed by cesium chloride gradient centrifugation [18). The puri-
fied RNA was quantified by reading the optical density at 260 nm, 
and size was confirmed on a 1 % agarose gel, with 18S and 28S 
ribosomal RNA visualized by ultraviolet light after ethidium bro-
mide staining. The RNA was stored under ETOH at -20°C. The 
RNA was transferred to nitrocellulose with vacuum pressure 
through a 24-well slot-blot apparatus in 10 X sodium citrate/so-
dium chloride buffer (1 X sodium citrate/sodium chloride buffer is 
0.15 M NaCl and 0.015 M sodium citrate). For IL-IO' and IL-lra, 
two slots were loaded with 1.5 and 0.75,ug RNA; for 28S blots, two 
slots were loaded with 10 and 5 ng RNA. The blots were then baked 
under vacuum at 80°C for 90 min. The following cDNA probes 
were utilized: A 800-bp cDNA probe for IL-lra (Synergen); a 1.4-
kb cDNA probe for 28S ribosomal RNA (Dr. R. Mahalingam, 
University of Colorado HSC, Denver, CO); and a 1.5-kb cDNA 
probe for IL-IO' (Dr. Michael Smith, Jr., University of Colorado 
HSC) [19). All probes were nick translated with 32P-labeled cyto-
sine (Bethesda Research Laboratories, Bethesda, MD) to a specific 
activity of 8.0 X 107 cpm/,ug or greater. The blots were pre-hybri-
dized and hybridized at 42°C and washed at 50 °C, as previously 
described [20). Autoradiographs were exposed at -70°C (IL-IO' 
and IL-lra) or at room temperature (28S) under intensifying 
screens. The developed autoradiographs were scanned by a BioRad 
Model 620 Video Densitometer (BioRad, Richmond, CA). Scans 
were analyzed by Microsoft Windows/286 Version 2.11 (Micro-
soft, Redmond, WA). The relative densitometric units for IL-1ra 
and IL-IO' were divided by those for 28S ribosomal RNA to correct 
for variations in amounts of total RNA added to each slot. 
Significance Testing Significant differences between groups 
were evaluated using the Student t test. 
RESULTS 
Effect of Various Cytokines on the Accumulation ofIL-lra 
and IL-10' by Keratinocytes Keratinocytes were cultured for 
48 h with various cytokines. The supernatants and lysates were then 
harvested and assayed for IL-1 ra and IL-10' protein levels. The 
treated cells were compared with control cells that did not receive 
any cytokines. Figure 1 depicts the results of this experiment. Only 
TNF-O' 10 ng/ml stimulated any substantial increase in IL-1ra ac-
cumulation when compared with the control cells. In this experi-
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Figure 4. Production of IL-lfr by four keratinocyte strains over 72 h. The legend is identical to that of Fig 3, except that IL-lfr is depicted instead oEIL-ira. 
ment, however, TNF-o: failed to enhance IL-lo: accumulation by 
the keratinocytes. Other cytokines may have induced low levels of 
IL-10: accumulation or interfered with baseline IL-lra levels, but 
the results were not as striking as those with TNF-o:. Further studies 
were performed only with TNF-o:; the possible decrease in baseline 
IL-1 ra levels observed with macroph3ge colony-stimulating factor 
is being explored in current experiments. 
TNF-a Stimulates IL-la and IL-lra Production in Cultured 
Keratinocytes Cultured keratinocytes spontaneously produce 
IL-10: and the intracellular structural variant of IL-lra. In these 
experiments, we examined in further detail the ability ofTNF-o: to 
induce additionallL-la and IL-lra production. Keratinocytes were 
cultured with varying concentrations ofTNF-a and cell superna-
tants and Iysates were collected at 12, 24, 48, and 72 h. IL-lo: and 
IL-1 ra concentrations in these samples were determined by sensitive 
and specific ELISA. 
The results from multiple experiments indicate that TNF-a stim-
ulated both IL-la and IL-1ra production by cultured keratinocytes 
in a concentration-dependent fashion . Results from a representative 
experiment at 48 h are presented in Fig 2. IL-l ra protein levels 
(lysates) were high in cells cultured without TNF-a (9.6 ± 1.2 
ng/m l; mean ± SD; n = 9) but nearly doubled after culture with 
TNF-o: 10 ngJml (17.6 ± 1.2 ng/ml). Baseline IL-la levels were 
lower (1.0 ± 0.3 ngJml) but increased threefold after culture with 
TNF-a 10 ng/ml (3.3 ± 0.2 ngjmJ). Both of these differences 
between TNF-a-stimulated and control cells were significant at 
p < 0.001. Similar results were observed with keratinocytes cul-
tured for 72 h (data not shown). In most experiments, almost all of 
the IL-lo: and IL-l ra produced was in the celt Iysates. 
The effects of culture in TNF-a on keratinocyte number were 
assessed in a control experiment. Keratinocytes cultured without 
TNF-a exhibited no change in cell number at 24 h, a 32% increase 
over 48 h and a 43% increase over 72 h, as determined by automated 
counting of solubilized cells. In contrast, keratinocytes cultured in 
TNF-a at all three concentrations exhibited little change in cell 
numbers over 48 and 72 h. The cell numbers for keratinocytes 
cuttured in TNF-<x were 98%, 57%, and 58% of the values for 
control cells at 24, 48, and 72 h, respectively. Because keratinocyte 
numbers were not routinely determined, the data were expressed as 
nanograms per miHihter of IL-lo: or IL-l ra. However, if expressed 
as percentages of control cells at 48 and 72 h, the values for IL-la 
and IL-lra produced by TNF-a-stimulated cells would be at least 
50% higher. 
Pattern of IL-la and IL-lra Production over Time Varies 
Between Different Keratinocyte Strains When examined at 
serial times, the patterns of IL-la and IL-lra production varied 
considerably between keratinocyte strains. Figures 3 and 4 depict 
the production patterns of IL-tra or IL-ta from four keratinocyte 
strains over 72 h. The total IL-l ra and IL-1a produced in each 
experiment (supernatants and Iysates) was determined at different 
time points after stimulation with 10 ng/ml TNF-a. These values 
were compared with those from control cells harvested at the same 
times in the absence ofTNF-a stimulation. The resul ts indicate that 
a different pattern ofIL-lra and IL-la production was exhibited by 
cells in each of the four experiments (Fig 3). In general, thekeratino· 
cyte strains showed either a decrease or an increase in IL-l ra produc-
tion over control values over the first 24 h. Some keratinocyte 
strains continued to exhibit declining amounts of IL-lra, whereas 
other strains showed an. increase il1lL-lra levels over control values. 
The keratinocyte strains also exhibited different patterns of IL-la 
response to TNF-a stimulation (Fig 4) . In all cases, however, the 
keratinocyte strains respond.ed to the TNF-a stimulation with earl 
(12 h) IL-ta production (p < 0.001; 12 h with TNF-a versus 12-h 
controls; n = 4) . Whether this IL-la response was sustained over 
the remainder of the 72-h culture period varied among the strain 
and did not always correlate with the pattern ofIL-lra production 
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Figure 5. Thirteen keratinocyte strains were tested for IL-lra and IL-Ia 
production in response to TNF-a stimulation. Not every strain was tested at 
the same time interval, but all were tested with the same dose ofTNF-a (i.e., 
10 ng/ml). The data are expressed as fold-increase in IL-la (a) or IL-l ra (b) 
production in response to TNF-a compared with control wells in the same 
experiment without TNF-a and harvested at the same time. 
by the same keratinocyte strain. Of importance, the IL-lra and 
IL-la response patterns to TNF-a stimulation were not linked for 
any of the keratinocyte strains examined. 
Compiled Results on IL-lra and IL-lO' Production Cells 
from 13 keratinocyte strains were evaluated separately for IL-la 
and IL-lra production at 12,24,48 and/or 72 h after culture with 
10 ng/ml TNF-a. The compiled data are presented in Fig 5 as times 
increase in IL-lO' or IL-1ra production in response to TNF-O' stimu-
lation over unstimulated cells. The results indicate considerable 
heterogeneity in levels ofIL-l ra or IL-lO' production among kerati-
nocyte strains over time. Cells from some keratinocyte strains exhib-
ited early IL-la or IL-lra production in response to TNF-O', 
whereas other strains exhibited this response later or not at all. We 
also directly compared the times increase in IL-l ra with that of 
IL-la in the same sample to determine whether the values changed 
in a coordinate fashion after TNF-a stimulation. There was no 
correlation between the times increase in IL-1ra versus that in IL-1a 
for values measured on the same samples from the same experiment 
(r 2 = 0.079; p > 0.05) . 
IL-la and IL-lra mRNA Levels To determine whether 
mRNA levels in keratinocytes follow the same pattern as protein 
production, total RNA was extracted from cultured cells at 12, 24, 
and 48 h and ill vitro hybridization experiments were performed 
using specific cDNA probes. Northern blot analysis indicated that 
each cDNA probe hybridized to only one mRNA and of the appro-
priate size (data not shown) . At 12 h of culture, the unstimulated 
cells contained low relative steady-state levels of IL-1O' mRNA (Fig 
6a ) and IL-lra mRNA (Fig 6b). A progressive increase in mRNA 
levels was observed in response to TNF-a at 10, 30, and 100 ng/ml. 
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Figure 6. Relative steady-state levels of lL- l a (a) and IL- lra (b) mRNA in 
keratinocytes at 12 h of culture with 0 , 10, 30, or 100 ng/ml TNF-a. The 
data are expressed as relative densitometric units from slot-blot experiments. 
The densitometric units for IL-I a or IL-Ira mRNA wcre corrected by thc 
value for 28S ribosomal RNA determined in a parallel slot. IL-la mRNA. 
IL-lra mRNA. and 28S RNA values were determined on the same sample of 
total RNA extracted from either TNF-a-stimulated or unstimulated cul -
tures. 
At 24 and 48 h. some relative steady-state levels ofIL-lO' and IL-1ra 
were present in unstimulated cells; an increase was observed in 
response to TNF-a stimulation, but a dose-response pattern was not 
observed (data not shown). Because the scannin g units for IL-la 
and IL-1ra mRNA were corrected by the values for 28S ribosomal 
RNA. the IL-la and IL-lra mRNA levels were corrected for possi-
ble changes in cell number. 
Culture of Keratinocytes on ECMP Does Not Alter the Pat-
terns ofIL-lO' and IL-lra Accumulation ECMP are known to 
alter some phenotypic characteristics of adherent cel ls. Keratino-
cytes were cultured for 72 h on pre-formed matrices of laminin. 
fibronectin, vitronectin. and collagen types I and IV. IL- la and 
IL-l ra protein concentrations in cell supernatants and lysates were 
determined by ELISA. N o changes iniL-la (Fig 7a) or IL-lra (Fig 
7b) protein levels were observed with keratinocytes cultured on 
matrices compared with uncoated plastic wells (control) . Keratino-
cytes cultured on vitronectin or collagen type IV in other experi-
ments gave similar negative results. In one experiment. 10 ng/ml 
TNF-a was added during the last 48 h of a 72-h keratinocyte cul-
ture on the matrices. The levels of IL-lra and IL-la proteins were 
the same in keratinocytes cultured with TNF-a either on uncoated 
plastic or on matrices (data not shown) . 
DISCUSSION 
The data in this study indicate that TNF-a induces production of 
both IL-la and IL-lra in cultured human keratinocytes. These pro-
teins largely remained intracellular and were accompanied by in-
creases in leve ls of the respective mRNAs. Furthermore. the pat-
terns ofIL-la and IL-l ra production by kcratinocytes in response to 
TNF-a varied from one another within a particular keratinocyte 
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Figure 7. IL-IQ or IL-l ra protein production by keratinocytes cultured on 
various connective tissue matrices. The matrices were prepared as described 
in Materials GIld Methods, and keratinocytes were cultured through 72 h. The 
data arc expressed as total IL-l Q (a) or IL-l ra (b) in nanograms per milliliter 
(supernatants and lysates) versus the matrix protein with cells cultured for 
12. 24, 48, or 72 h. The O-h values represent IL-IQ or IL-lra proteins 
present in keratinocytes at the beginning of the culture period. IL-l ra and 
IL-IQ were measured on the same samples. Each bar represents the mean of 
triplicate cultures, with triplicate samples assayed from each culture. 
strain, and for each cytokine the patterns also varied between kerati-
nocyte strains. In addition, IL-la and IL-l ra accumulation was not 
induced by culrure of keratinocytes on ECMP, such as laminin, 
fibronectin, vitronectin, and collagen types I and IV. 
Numerous studies have described the characteristics ofIL-la and 
IL-l/3 production by cultured keratinocytes and by keratinocyte cell 
lines (summarized in [21,22]) . The only published results on cyto-
kine effects showed that IL-la, TNF-a, and granulocyte-macro-
phage colony-stimulating factor induced IL-la mRNA expression 
in the murine Pam 212 keratinocyte cellime [23]. Our studies are 
the first to examine IL-lra production by keratinocytes in response 
to cycokines and indicate that TNF-a induces both IL-1a and IL-
lra in these cells. 
There are a few technical considerations that warrant comment. 
Our results on IL-la and IL-l ra production by cultured keratino-
cytes were not normalized to any standard for cell number. It was 
not possible to determine total protein production by the cultured 
keratinocytes, as a reflection of cell number, because the medium 
contained too high a protein concentration. However, it is unlikely 
that differences in cell number influenced the observed variable 
patterns in IL-la and IL-lra production by keratinocytes cultured 
with TNF-a. The cells were always plated at the same density, 
harvested at the same times, and did not exhibit marked variations in 
rates of growth among strains. Furthermore, TNF-a has been re-
ported to retard rather than enhance keratinocyte proliferation in 
vitro [24,25] . In a control experiment, we observed that cell numbers 
in keratinocytes cultured with aJl three concentrations of TNF-a 
were 57% of those in control cultures at 48 h. Thus, if corrected for 
cell number as a percent of control, the values for IL-la and IL-lra 
production in the presence ofTNF-O' would be at least 50% higher. 
The variations in extent and pattern of IL-Ia and IL-Ira produc-
tion by control or TNF-a-stimulated keratinocytes may reflect 
intrinsic differences among keratinocyte strains. However, we were 
unable for technical reasons to repeat studies on a particular keratino-
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cyte strain at a later point in time. Some keratinocyte cultures exhib, 
ited high initial levels of IL- IO' and IL-1 ra production with de, 
creases over time in culture. It is possible that the high initial 
cytokine production in these cells refl ected in lIillo stimulation. Be, 
cause most of the IL-la and IL-l ra synthesized remained intracel, 
lular, the decreasing levels over time may have been due to degrada, 
cion inside the cell. It should be emphasized that our studies, lik~ 
most others on cytokine production i/1 IIitro, determined only level~ 
found after a particular duration of culture. The kinetics of rates ot 
production and degradation were not assessed, although both rna)' 
occur simultaneously. 
Our results show considerable variability in the levels and pat, 
terns oflL-la and IL-lra production in response to TNF-a stimula, 
tion of different keratinocyte strains. In extensive experiments 01\ 
TNF-a - induced illtercellular matrix adhesion molecule-l expres, 
sion on human keratinocytes, we found that cell strains from differ, 
ent donors exhibit different but consistent patterns of response.:!: To. 
verify this point concerning IL-Ia and IL-lra production in re, 
sponse to TNF-a, we plan to study keratinocytes from suction bl is, 
ters harvested from adult donors at different times. Similar experi, 
ments cannot be performed with cultured neonatal foreskil\ 
keratinocytes. 
Both IL-la and IL-lra are found in abundant amounts in the skill 
i,·/ lIillo [7,22,23]; however, it is not known whetherTNF-a exhibit 
a similar stimulatory effect on production of these cytokines ill 
intact skin. TNP-a is cytostatic, not mitogenic, for normal humal\ 
keratinocytes [26J; however, TNF-a is produced by keratinocyt~ 
and may play an important role in inflammatory events in the skil\ 
[27,28]. The induction of IL-IO' and IL-1ra production by TNF-<x 
further expands the described effects of this cytokine on keratino, 
cytes. 
IL-1a and TNF-a have been termed primary cytokines in the skill 
and in other organs, leading to tissue inflammation through the 
induction of other cytokines and mediator molecules. IL-la, TNF, 
a, and IL-lra may be produced by additional cells besides keratino, 
cytes in the skin, including infiltrating neutrophil s and macro-
phages in inflammatory disorders. An imbalance in production ot 
these three cytokines may playa role in psoriasis [29] or in cutaneous 
T-cell lymphoma [30]. However, the potentially pro-inflammatory 
effects of IL-1a in the skin may be influenced by the relative 
amounts ofIL-lra present. The ratio ofIL-lra to IL- ta is approxi-
mately 100 in normal skin but exceeds 1000 in psoriatic lesions [7]. 
These relative amounts of IL-lra are sufficient to inhibit 50% or 
greater target cell responses to IL-l via the type I receptor, an effect 
requiring 10- 100 times greater amounts of IL-1ra over IL-IO'. It 
should be noted that the levels of IL-l ra produced by keratinocytes 
in the present studies were lower than in our previous studies [6], 
and the ratios of IL-lra to IL-la usually did not exceed ten time' 
[31). Keratinocytes express type I IL-l receptors and respond to IL-l 
stimulation with enhanced production of granulocyte-macrophage 
colony-stimulating factor and IL-6 [21,32]. Of interest, keratino-
cyte differentiation is accompanied by increased expression ofIL-l 
receptors [33) and enhanced production of IL- lra [6), but IL-la 
production is unchanged [6,33]. In addition, lL-1 receptor expres-
sion is increased in psoriatic plaques. The balance between IL-l and 
IL-lra may playa role in function of keratinocytes ill lIi/IO in thi 
disease. 
TNF-a release can be triggered by ultraviolet radiation [28]. Vari, 
ability in response to TNF-a has been proposed as an importan\ 
genetic determinant of ultraviolet-induced immunosuppression am! 
carcinogenesis [34,35]. Production of TNF-a in the epidermis cal\ 
also be triggered by tape-stripping or acetone disruption of th~ 
stratum corneum (36].§ This TNF-a response to barrier disruptiol\ 
may be an important pro-inflammatory factor in a number of skiQ 
:j: Middleton MH, Kashihara-Sawami M, Norris DA: A strong correlatio~ 
between tumor necrosis factor alpha and ultraviolet radiatioll- induced e~, 
pression of ICAM-l in individual keratinocyte strains (in preparation). 
§ Wood LC,]ackson S, Elias PM, Grunfeld C, Feingold KR: Permeability 
barrier disruption stimulates epidermal cytokil1c production (abstr.). J InveSI 
Dermatol 98:381A, 1992. 
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diseases with defective epidermal barrier funct ion. It is likely that 
release of intradermal TNF-l1' may have broad biologic conse-
quences. 
In summary, we have observed that cultured keratinocytes ex-
hibit enhanced production of both IL-ll1' and IL-lra after TNF-l1' 
stimulation. In contrast, culture on ECMP does not induce keratino-
cyte accumul at ion of these two forms of IL-l. The relevance of 
these observations to inflammatory events in the skin is not known. 
Perhaps further ill vivo studies will clarify this issue. 
This work was slipported by Natiolla l Institlltes of Health grotlts 5T32AR07411 
(eLK, DAN), AR39950 (WPA), alld AR40135 (WPA) 
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